Clinical trial
A Noninterventional Genotype/Phenotype Study of mGluR Mutations in Children and Adolescents With Attention Deficit Hyperactivity Disorder (ADHD)
NCT02811211 is registered in ClinicalTrials.gov with Aevi Genomic Medicine, LLC, a Cerecor company as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- A Noninterventional Genotype/Phenotype Study of mGluR Mutations in Children and Adolescents With Attention Deficit Hyperactivity Disorder (ADHD)
- Lead sponsor
- Aevi Genomic Medicine, LLC, a Cerecor company
- Phase
- Observational
- Overall status
- Completed
- Start date
- February 29, 2016
- Completion date
- January 6, 2017
- Enrollment
- 1,894 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.